A noninterventional study of everolimus in metastatic renal cell cancer after use of one VEGFR-TKI: Results of a preplanned interim analysis of a prospective study.
L. Bergmann
Consultant or Advisory Role - Novartis
Honoraria - Novartis
U. Kube
No relevant relationships to disclose
M. Kindler
No relevant relationships to disclose
T. Koepke
No relevant relationships to disclose
G. Steiner
No relevant relationships to disclose
J. Janssen
No relevant relationships to disclose
S. Fries
No relevant relationships to disclose
P. Goebell
Honoraria - speech at study meeting
A. Jakob
Honoraria - Novartis
T. Steiner
Consultant or Advisory Role - Amgen; Bayer; GlaxoSmithKline; Novartis; Pfizer
M. D. Staehler
Consultant or Advisory Role - Bayer; GlaxoSmithKline; Novartis; Pfizer
F. Overkamp
No relevant relationships to disclose
M. Albrecht
Employment or Leadership Position - Novartis
C. Doehn
Consultant or Advisory Role - GlaxoSmithKline
Honoraria - GlaxoSmithKline